Bone Biologics regains Nasdaq minimum bid price compliance

Bone Biologics Corp

Received Nasdaq notice on June 25, 2025 confirming compliance with Listing Rule 5550(a)(2).
Non-compliant since April 7, 2025; regained by maintaining $1.00 closing bid price for 10 consecutive days through June 24, 2025.
Common stock (BBLG) and warrants (BBLGW) continue trading on Nasdaq Capital Market.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.